Technology

Antibody Discovery Platform – INABLR^®

Technology Platform Assets

Zumutor’s Antibody Discovery Program

INABLR^® – Process Flow

Germline family distribution of Heavy chain “V” genes

Zumutor’s ADCC improvement platform is ready to deploy

Zumutor has developed multiple expression platforms which lead to improvement of antibody dependent cellular cytotoxicity of therapeutic antibodies. The ADCC Improvement Platform and methods of development are unique and we have filed patent applications to secure global IP rights. All R &D activities related to our ADCC Improvement Platform are carried out in our facilities in India

Discover The Future

We are a multi-disciplinary laboratory committed to focussed and efficient drug discovery

Contact Us